Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

SERUM COMPLEMENT ACTIVITY TEST-SCAT

K-Number: K841541 · 1984-06-01

ApplicantCollaborative Research, Inc.
Decision Date1984-06-01
Product CodeDAK
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

SERUM COMPLEMENT ACTIVITY TEST-SCAT is the device name listed in this FDA 510(k) record. The listed applicant is Collaborative Research, Inc.. It received FDA 510(k) clearance on 1984-06-01 under 510(k) number K841541. The device is classified under product code DAK. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SERUM COMPLEMENT ACTIVITY TEST-SCAT?

SERUM COMPLEMENT ACTIVITY TEST-SCAT is a medical device that received FDA 510(k) clearance on 1984-06-01. The listed applicant is Collaborative Research, Inc.. The 510(k) number is K841541.

When did SERUM COMPLEMENT ACTIVITY TEST-SCAT receive FDA 510(k) clearance?

SERUM COMPLEMENT ACTIVITY TEST-SCAT received FDA 510(k) clearance on 1984-06-01, under 510(k) number K841541.

Who is the listed applicant for SERUM COMPLEMENT ACTIVITY TEST-SCAT?

The FDA 510(k) record lists Collaborative Research, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for SERUM COMPLEMENT ACTIVITY TEST-SCAT?

The FDA product code for SERUM COMPLEMENT ACTIVITY TEST-SCAT is DAK.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Collaborative Research, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K840241THYROXINE EMIA

Related Devices (Code: DAK)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K031563BINDAZYME CLQ CIC EIA KITThe Binding Site, Ltd.K032254IBL C1Q-CIC CIA TESTIbl GmbHK012576CIC-C1Q EIAAmerican Laboratory Products Co., Ltd.K973203THYMOSTAT ELISA FOR THE DETECTION OF HUMAN IGG,M AND A ANTI-RABBIT IGG ANTIBODIESSangstat Medical Corp.K972873IMMUSTRIP HAMA IGGImmunomedics, Inc.K951968HUMAN C1Q RADIAL IMMUNODIFFUSION KITKent Laboratories, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑